SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-031153
Filing Date
2024-03-14
Accepted
2024-03-14 08:00:35
Documents
83
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 6-K ipa-20240131.htm   iXBRL 6-K 260999
2 EX-99.1 ipa-ex99_1.htm EX-99.1 559102
3 EX-99.2 ipa-ex99_2.htm   iXBRL EX-99.2 2028332
4 EX-99.3 ipa-ex99_3.htm EX-99.3 23082
5 EX-99.4 ipa-ex99_4.htm EX-99.4 21516
6 GRAPHIC img36100363_0.jpg GRAPHIC 8744
7 GRAPHIC img37023884_0.jpg GRAPHIC 8744
  Complete submission text file 0000950170-24-031153.txt   12693303

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ipa-20240131.xsd EX-101.SCH 1867573
84 EXTRACTED XBRL INSTANCE DOCUMENT ipa-20240131_htm.xml XML 3097759
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 24747972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)